ApicHope Pharmaceutical (300723.SZ) Earnings Analysis

ApicHope Pharmaceutical (300723.SZ) next reports earnings on 2026-08-27. Trailing P/E 80.75.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300723.SZ next report earnings?

Next earnings date2026-08-27
Consensus EPS estimaten/a
Revenue estimaten/a

300723.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-231.32 CNYn/an/an/a
2025-10-30-0.14005 CNYn/an/an/a
2025-04-24-0.64983 CNYn/an/an/a
2025-03-310.1267 CNYn/an/an/a

300723.SZ valuation and analyst view

Trailing P/E80.75
Trailing EPS0.44277 CNY
Price / book8.29
Dividend yield0.00%
Market cap16.26B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is ApicHope Pharmaceutical (300723.SZ)'s next earnings date?

ApicHope Pharmaceutical is next scheduled to report on 2026-08-27.

Did 300723.SZ beat earnings last quarter?

Consensus estimate data was not available for 300723.SZ's 2026-04-23 report.

What is 300723.SZ's current P/E ratio and EPS?

300723.SZ trades at a trailing P/E of 80.75 on trailing EPS of 0.44276764516006195 CNY.

What do analysts rate 300723.SZ?

300723.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.